Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.63−0.06 (-3.55%)
Close on Nov 17, 2026Market cap $2.66MP/E –Yield –
Ernexa Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ernexa Therapeutics's price to book ratio was 0.7× on Nov 11, 2026, against 74.2× a year earlier. Over the last 5 years it ranged from 0.5× to 457.3×, with a median of 188.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −65.3 |
| 2025 | Dec 31, 2025 | 66.0× | −391.4 |
| 2023 | Apr 28, 2023 | 457.3× | +54.3 |
| 2022 | Dec 30, 2022 | 403.1× | +292.2 |
| 2019 | Oct 31, 2019 | 110.9× | −99.6 |
| 2018 | Jan 31, 2018 | 210.4× | +53.1 |
| 2017 | Dec 29, 2017 | 157.4× | −280.1 |
| 2013 | Oct 31, 2013 | 437.4× | +252.7 |
| 2012 | Dec 31, 2012 | 184.7× | −3.7 |
| 2011 | Dec 30, 2011 | 188.4× | – |
See a number that looks wrong?